Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties
A. Adam Sharkawy, Bruce M. Klitzman, George A. Truskey et al. · Journal of Biomedical Materials Research · 1998
This study assesses the plasma-tissue exchange characteristics of the capsular tissue that forms around implants and how they are affected by implant porosity. The number of vessels and their permeability to rhodamine were measured by intravascular injection of the fluorophore tracer into Sprague-Dawley rats that hosted for 3-4 months polyvinyl alcohol (PVA) and polytetrafluoroethylene (PTFE) subcutaneous implants. Rats were implanted with four pore sizes of PVA--a nonporous PVA (PVA-skin), and 5, 60, and 700 micron mean pore sizes (PVA-5, PVA-60, and PVA-700, respectively)--and two pore sizes of PTFE: 0.50 (PTFE-0.5) and 5.0 (PTFE-5) mean micron pore sizes. Photodensitometric image analysis was used to quantify the local tracer extravasation and, hence the permeability coefficients of isolated vessels around the implants. The number of functional vessels within 100 microm of the implants highlighted by the lissamine-rhodamine tracer were counted with fluorescence microscopy and with H&E stained sections using brightfield microscopy. The permeability of vessels did not vary substantially with implant pore size but generally were lower than those measured for surrounding subcutis. Pore size, however, had a dramatic effect on the vascular density of tissue-encapsulating implants: the number of microvessels (under 10 microm in radius) within the tissue surrounding the porous implants was higher than the number around nonporous implants. Pore sizes on the order of cellular dimensions incited optimal neovascularization; the vascular density around PVA-60 implants was six times higher (p < .001) and three times higher (p < .001) than those around PVA-0 implants in the fluorescent images and in brightfield, respectively. Moreover, brightfield microscopy showed the number of vessels around PVA-60 implants was almost double those in normal subcutis. The results suggest that optimal vascular density around long-term implants, such as sensors, biofluid cell constructs, and immunoisolated cell systems, may be engineered with pore size.
Cited by 145 works. doi:10.1002/(sici)1097-4636(19980615)40:4<586::aid-jbm10>3.0.co;2-e Open-access PDF
Authors
References
- Microvascular Permeability of Albumin, Vascular Surface Area, and Vascular Volume Measured in Human Adenocarcinoma LS174T Using Dorsal Chamber in SCID Mice
- Neovascularization of synthetic membranes directed by membrane microarchitecture
- Definitive proof of endothelialization of a dacron arterial prosthesis in a human being
- Evaluation of a Subcutaneous Glucose Sensor out to 3 Months in a Dog Model
- Measurement of vascular volume fraction and blood‐tissue permeability constants with a pharmacokinetic model: Studies in rat muscle tumors with dynamic Gd‐DTPA enhanced MRI
- Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties
- How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensors
- [Measuring EEG complexity for studying the state of mental load].
- Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality?
- Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.